Sabra Healthcare REIT (NASDAQ:SBRA) Given New $23.00 Price Target at Wells Fargo & Company

Sabra Healthcare REIT (NASDAQ:SBRA – Get Free Report) had its price target raised by investment analysts at Wells Fargo & Company from $21.00 to $23.00 in a research report issued to clients and investors on Monday, Benzinga reports. The firm presently has an “overweight” rating on the real estate investment trust’s stock. Wells Fargo & Company‘s target price points to a potential upside of 11.80% from the company’s current price.

SBRA has been the subject of several other research reports. Deutsche Bank reissued a “buy” rating on shares of Sabra Healthcare REIT in a report on Wednesday, July 22nd. Citigroup reiterated a “market outperform” rating on shares of Sabra Healthcare REIT in a research report on Wednesday, July 22nd. Robert W. Baird boosted their target price on Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “neutral” rating in a research report on Monday, August 31st. Weiss Ratings raised Sabra Healthcare REIT from a “hold (c)” rating to a “buy (b-)” rating in a research note on Tuesday, November 3rd. Finally, Barclays cut their price target on Sabra Healthcare REIT from $23.00 to $21.00 and set an “equal weight” rating for the company in a report on Tuesday, October 13th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $21.83.

Read Our Latest Stock Analysis on SBRA

Sabra Healthcare REIT Stock Performance

SBRA opened at $20.57 on Monday. The stock has a market capitalization of $5.39 billion, a price-to-earnings ratio of 74.36, a PEG ratio of 1.78 and a beta of 0.68. The company has a fifty day moving average of $19.88 and a 200 day moving average of $20.04. Sabra Healthcare REIT has a fifty-two week low of $17.53 and a fifty-two week high of $22.77. The company has a debt-to-equity ratio of 0.86, a quick ratio of 1.21 and a current ratio of 1.21.

Sabra Healthcare REIT (NASDAQ:SBRA – Get Free Report) last announced its quarterly earnings results on Monday, November 2nd. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.16 by ($0.05). The company had revenue of $249.57 million during the quarter, compared to the consensus estimate of $236.64 million. Sabra Healthcare REIT had a net margin of 7.78% and a return on equity of 2.55%. The business’s revenue was up 31.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.38 earnings per share. As a group, sell-side analysts forecast that Sabra Healthcare REIT will post 1.52 earnings per share for the current fiscal year.

Insider Buying and Selling at Sabra Healthcare REIT

In other news, CEO Richard K. Matros sold 200,000 shares of the stock in a transaction that occurred on Tuesday, September 8th. The stock was sold at an average price of $20.83, for a total value of $4,166,000.00. Following the sale, the chief executive officer directly owned 1,657,686 shares in the company, valued at approximately $34,529,599.38. This represents a 10.77% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Michael J. Foster sold 10,000 shares of the stock in a transaction that occurred on Wednesday, November 11th. The stock was sold at an average price of $20.98, for a total value of $209,800.00. Following the completion of the sale, the director owned 72,834 shares in the company, valued at approximately $1,528,057.32. The trade was a 12.07% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 1.09% of the company’s stock.

Hedge Funds Weigh In On Sabra Healthcare REIT

Several hedge funds have recently bought and sold shares of the business. Rush Island Management LP purchased a new stake in shares of Sabra Healthcare REIT during the first quarter valued at about $30,735,000. William Blair Investment Management LLC purchased a new position in shares of Sabra Healthcare REIT in the 3rd quarter worth approximately $16,545,000. Russell Investments Group Ltd. grew its position in shares of Sabra Healthcare REIT by 70.2% in the 3rd quarter. Russell Investments Group Ltd. now owns 1,856,730 shares of the real estate investment trust’s stock worth $36,615,000 after buying an additional 765,527 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund grew its position in shares of Sabra Healthcare REIT by 161.0% in the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 926,972 shares of the real estate investment trust’s stock worth $18,280,000 after buying an additional 571,743 shares during the last quarter. Finally, BROOKFIELD Corp ON purchased a new position in shares of Sabra Healthcare REIT in the 1st quarter worth approximately $9,710,000. Institutional investors own 99.40% of the company’s stock.

Sabra Healthcare REIT Company Profile

(Get Free Report)

Sabra Health Care REIT, Inc. is a real estate investment trust that owns and invests in properties used to provide healthcare and senior living services. Its portfolio includes skilled nursing and transitional care facilities, senior housing communities, behavioral health facilities, and specialty hospitals. Sabra generally leases its properties to healthcare and senior living operators, providing real estate that supports their services. The company’s properties are located in the United States and Canada.

Read More

Analyst Recommendations for Sabra Healthcare REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.